美国上市药品（最近批准）
按批准日期最近更新
| 药品名称 | 商品名 | 申请号 | 产品编号 | 剂型 | 规格 | 企业 | 市场状态 | 批准日期 | 上市日期 |
|---|---|---|---|---|---|---|---|---|---|
| PERAMPANEL | PERAMPANEL | ANDA220492 | 005 | TABLET;ORAL | 10MG | AUROBINDO PHARMA LTD | Prescription | 2026-10-02 | 2026-10-02 |
| PERAMPANEL | PERAMPANEL | ANDA220492 | 006 | TABLET;ORAL | 12MG | AUROBINDO PHARMA LTD | Prescription | 2026-10-02 | 2026-10-02 |
| TRABECTEDIN | TRABECTEDIN | NDA219617 | 001 | INJECTABLE;INJECTION | 1MG | EVER VALINJECT | None (Tentative Approval) | 2026-10-01 | 2026-10-01 |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | ANDA219408 | 001 | TABLET | 5MG | SCIEGEN PHARMACEUTICALS INC | None (Tentative Approval) | 2026-10-01 | 2026-10-01 |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | ANDA219408 | 002 | TABLET | 10MG | SCIEGEN PHARMACEUTICALS INC | None (Tentative Approval) | 2026-10-01 | 2026-10-01 |
| LEVOCARNITINE | LEVOCARNITINE | ANDA220181 | 001 | INJECTABLE;INJECTION | 200MG/ML | GLAND | Prescription | 2026-09-30 | 2026-09-30 |
| LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | ANDA220722 | 001 | CAPSULE;ORAL | 2MG | TARO | Over-the-counter | 2026-09-30 | 2026-09-30 |
| PHYTONADIONE | PHYTONADIONE | ANDA219175 | 001 | INJECTABLE;INJECTION | 1MG/0.5ML | LUPIN | Prescription | 2026-09-30 | 2026-09-30 |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | ANDA211414 | 001 | UNKNOWN | UNKNOWN | BIONPHARMA INC | None (Tentative Approval) | 2026-09-29 | 2026-09-29 |
| MUPIROCIN CALCIUM | MUPIROCIN CALCIUM | ANDA218361 | 001 | CREAM;TOPICAL | EQ 2% BASE | ZYDUS LIFESCIENCES | Prescription | 2026-09-29 | 2026-09-29 |
上一页 第 3 / 3 页 下一页